Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2002;2(3):203–209. doi: 10.1007/s11882-002-0020-3

Thoughts on the pathophysiology of nonallergic rhinitis

Wytske J Fokkens 1
PMCID: PMC7089100  PMID: 11918861

Abstract

Nonallergic noninfectious rhinitis is a diagnosis by exclusion, meaning that a number of poorly defined nasal conditions that have in common allergy and infection as a cause of the rhinitis have been excluded. The etiology of some subgroups of nonallergic noninfectious rhinitis, like nonallergic rhinitis with eosinophilia (NARES) and drug-induced rhinitis, are quite well defined, but in the majority of the patients, the etiology and pathophysiology are unknown. These patients are classified as idiopathic rhinitis patients. A careful determination of the intensity of the symptoms combined with modern diagnostic tools enables us to discriminate idiopathic rhinitis patients from normal controls. This review discusses the possible pathophysicologic mechanisms of nonallergic noninfectious rhinitis, with emphasis on idiopathic rhinitis.

Keywords: Rhinitis, Capsaicin, Allergic Rhinitis, Nasal Mucosa, Allergy Clin Immunol

References and Recommended Reading

  • 1.International Rhinitis Management Working Group international consensus report on the diagnosis and management of rhinitis. Allergy 1994, 49(Suppl 19):1-34. [PubMed]
  • 2.Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81:478–518. doi: 10.1016/s1081-1206(10)63155-9. [DOI] [PubMed] [Google Scholar]
  • 3.Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147–S334. doi: 10.1067/mai.2001.118891. [DOI] [PubMed] [Google Scholar]
  • 4.Slavin RG. Occupational rhinitis. Ann Allergy Asthma Immunol. 1999;83:597–601. doi: 10.1016/S1081-1206(10)62879-7. [DOI] [PubMed] [Google Scholar]
  • 5.Sari-Minodier I, Charpin D, Signouret M, et al. Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates. J Occup Environ Med. 1999;41:582–588. doi: 10.1097/00043764-199907000-00006. [DOI] [PubMed] [Google Scholar]
  • 6.Leroyer C, Malo JL, Girard D, et al. Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine. Occup Environ Med. 1999;56(5):334–338. doi: 10.1136/oem.56.5.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shusterman D, Balmes J. Measurement of nasal irritant sensitivity to pulsed carbon dioxide: a pilot study. Arch Environ Health. 1997;52:334–340. doi: 10.1080/00039899709602208. [DOI] [PubMed] [Google Scholar]
  • 8.Mabry RL. Rhinitis of pregnancy. South Med J. 1986;79:965–971. doi: 10.1097/00007611-198608000-00012. [DOI] [PubMed] [Google Scholar]
  • 9.Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86:494–507. doi: 10.1016/S1081-1206(10)62896-7. [DOI] [PubMed] [Google Scholar]
  • 10.Jacobs RL, Freedman PM, Boswell RN. Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol. 1981;67:253–262. doi: 10.1016/0091-6749(81)90019-1. [DOI] [PubMed] [Google Scholar]
  • 11.Moneret-Vautrin DA, Hsieh V, Wayoff M, et al. Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy. 1990;64:513–518. [PubMed] [Google Scholar]
  • 12.Ingels K, Durdurez JP, Cuvelier C, van Cauwenberge P. Nasal biopsy is superior to nasal smear for finding eosinophils in nonallergic rhinitis. Allergy. 1997;52:338–341. doi: 10.1111/j.1398-9995.1997.tb01001.x. [DOI] [PubMed] [Google Scholar]
  • 13.Blom HM, Godthelp T, Fokkens WJ, et al. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol. 1997;100:739–747. doi: 10.1016/S0091-6749(97)70267-7. [DOI] [PubMed] [Google Scholar]
  • 14.Numata T, Konno A, Hasegawa S, et al. Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol. 1999;119:304–313. doi: 10.1159/000024208. [DOI] [PubMed] [Google Scholar]
  • 15.Sanico A, Togias A. Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol. 1998;12:65–72. doi: 10.2500/105065898782103043. [DOI] [PubMed] [Google Scholar]
  • 16.Blom HM, Van Rijswijk JB, Garrelds IM, et al. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy. 1997;27:796–801. doi: 10.1046/j.1365-2222.1997.670842.x. [DOI] [PubMed] [Google Scholar]
  • 17.van Wijk Gerth R, Dieges PH. Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology. 1994;32:119–122. [PubMed] [Google Scholar]
  • 18.Togias A, Lykens K, Kagey-Sobotka A, et al. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990;141:1428–1433. doi: 10.1164/ajrccm/141.6.1428. [DOI] [PubMed] [Google Scholar]
  • 19.Braat JP, Mulder PG, Fokkens WJ, et al. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med. 1998;157:1748–1755. doi: 10.1164/ajrccm.157.6.9701016. [DOI] [PubMed] [Google Scholar]
  • 20.Sanico AM, Philip G, Proud D, et al. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998;28:92–100. doi: 10.1046/j.1365-2222.1998.00182.x. [DOI] [PubMed] [Google Scholar]
  • 21.Togias AG, Naclerio RM, Proud D, et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985;76:1375–1381. doi: 10.1172/JCI112113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fokkens WJ, Holm AF, Rijntjes E, et al. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol. 1990;93:66–72. doi: 10.1159/000235281. [DOI] [PubMed] [Google Scholar]
  • 23.Amin K, Ludviksdottir D, Janson C, et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med. 2000;162:2295–2301. doi: 10.1164/ajrccm.162.6.9912001. [DOI] [PubMed] [Google Scholar]
  • 24.Svensson C, Andersson M, Greiff L, Persson CG. Nasal mucosal endorgan hyperresponsiveness. Am J Rhinol. 1998;12:37–43. doi: 10.2500/105065898782103016. [DOI] [PubMed] [Google Scholar]
  • 25.Powe DG, Huskisson RS, Carney AS, et al. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31:864–872. doi: 10.1046/j.1365-2222.2001.01106.x. [DOI] [PubMed] [Google Scholar]
  • 26.Blom H, Godthelp T, Fokkens W, et al. Mast cells, eosinphils and IgE-positive cells in the nasal mucosa of patients wiht vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngolg. 1995;252(Suppl 1):S33–S39. doi: 10.1007/BF02484432. [DOI] [PubMed] [Google Scholar]
  • 27.Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol. 1979;122:2218–2225. [PubMed] [Google Scholar]
  • 28.KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J. 2000;15:491–497. doi: 10.1034/j.1399-3003.2000.15.11.x. [DOI] [PubMed] [Google Scholar]
  • 29.Durham SR, Gould HJ, Thienes CP, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol. 1997;27:2899–2906. doi: 10.1002/eji.1830271123. [DOI] [PubMed] [Google Scholar]
  • 30.Vinke JG, KleinJan A, Severijnen LW, Fokkens WJ. Passive smoking causes an ‘allergic’ cell infiltrate in the nasal mucosa of non-atopic children. Int J Pediatr Otorhinolaryngol. 1999;51:73–81. doi: 10.1016/S0165-5876(99)00244-X. [DOI] [PubMed] [Google Scholar]
  • 31.Villar MT, Holgate ST. IgE, smoking and lung function. Clin Exp Allergy. 1995;25:206–209. doi: 10.1111/j.1365-2222.1995.tb01030.x. [DOI] [PubMed] [Google Scholar]
  • 32.Blom HM, Severijnen LA, Van Rijswijk JB, et al. The long-term effects of capsaicin aqueous spray on the nasal mucosa. Clin Exp Allergy. 1998;28:1351–1358. doi: 10.1046/j.1365-2222.1998.00421.x. [DOI] [PubMed] [Google Scholar]
  • 33.Lundblad L, Sipila P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2001;121:505–509. [PubMed] [Google Scholar]
  • 34.Lieberman P. Treatment update: nonallergic rhinitis. Allergy Asthma Proc. 2001;22:199–202. [PubMed] [Google Scholar]
  • 35.Banov CH, Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001;86:28–35. doi: 10.1016/S1081-1206(10)62352-6. [DOI] [PubMed] [Google Scholar]
  • 36.Silber G, Proud D, Warner J, et al. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988;137:606–612. doi: 10.1164/ajrccm/137.3.606. [DOI] [PubMed] [Google Scholar]
  • 37.Philip G, Sanico AM, Togias A. Inflammatory cellular influx follows capsaicin nasal challenge. Am J Respir Crit Care Med. 1996;153:1222–1229. doi: 10.1164/ajrccm.153.4.8616545. [DOI] [PubMed] [Google Scholar]
  • 38.Jankowski R, Philip G, Togias A, Naclerio R. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993;31:97–100. [PubMed] [Google Scholar]
  • 39.Togias A, Proud D, Kagey-Sobotka A, et al. The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol. 1987;79:599–604. doi: 10.1016/s0091-6749(87)80155-0. [DOI] [PubMed] [Google Scholar]
  • 40.Cruz AA, Togias AG, Lichtenstein LM, et al. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991;143:761–765. doi: 10.1164/ajrccm/143.4_Pt_1.761. [DOI] [PubMed] [Google Scholar]
  • 41.Baraniuk JN. Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol. 1992;90:1045–1050. doi: 10.1016/0091-6749(92)90121-H. [DOI] [PubMed] [Google Scholar]
  • 42.Anggard A. Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol. 1993;113:394–396. doi: 10.3109/00016489309135832. [DOI] [PubMed] [Google Scholar]
  • 43.Sanico AM, Atsuta S, Proud D, Togias A. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol. 1997;100:632–641. doi: 10.1016/S0091-6749(97)70167-2. [DOI] [PubMed] [Google Scholar]
  • 44.Baraniuk JN. Neuropeptides. Am J Rhinol. 1998;12:9–16. doi: 10.2500/105065898780707964. [DOI] [PubMed] [Google Scholar]
  • 45.Philip G, Baroody FM, Proud D, et al. The human nasal response to capsaicin. J Allergy Clin Immunol. 1994;94:1035–1045. doi: 10.1016/0091-6749(94)90122-8. [DOI] [PubMed] [Google Scholar]
  • 46.Stjarne P, Lundblad L, Lundberg JM, Anggard A. Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol. 1989;96:693–701. doi: 10.1111/j.1476-5381.1989.tb11870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Filiaci F, Zambetti G, Ciofalo A, et al. Local treatment of aspecific nasal hyperreactivity with capsaicin. Allergol Immunopathol (Madr) 1994;22:264–268. [PubMed] [Google Scholar]
  • 48.Rinder J, Stjarne P, Lundberg JM. Capsaicin de-sensitization of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline. Rhinology. 1994;32:173–178. [PubMed] [Google Scholar]
  • 49.Braat JP, Fokkens WJ, Mulder PG, et al. Forced expiration through the nose is a stimulus for NANIPER but not for controls. Rhinology. 2000;38:172–176. [PubMed] [Google Scholar]
  • 50.Jaradeh SS, Smith TL, Torrico L, et al. Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope. 2000;110:1828–1831. doi: 10.1097/00005537-200011000-00012. [DOI] [PubMed] [Google Scholar]
  • 51.Fernandes CM. Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol. 1994;108:569–573. doi: 10.1017/s0022215100127458. [DOI] [PubMed] [Google Scholar]
  • 52.Malmberg H, Grahne B, Holopainen E, Binder E. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol. 1983;8:273–276. doi: 10.1111/j.1365-2273.1983.tb01441.x. [DOI] [PubMed] [Google Scholar]
  • 53.Dockhorn R, Aaronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999;82:349–359. doi: 10.1016/S1081-1206(10)63284-X. [DOI] [PubMed] [Google Scholar]
  • 54.Georgitis JW, Banov C, Boggs PB, et al. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy. 1994;24:1049–1055. doi: 10.1111/j.1365-2222.1994.tb02742.x. [DOI] [PubMed] [Google Scholar]
  • 55.Wilde AD, Cook JA, Jones AS. The nasal response to isometric exercise in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol. 1996;21:84–86. doi: 10.1046/j.1365-2273.1996.00823.x. [DOI] [PubMed] [Google Scholar]
  • 56.Wilde D, Cook JA, Jones AS. The nasal response to axillary pressure in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol. 1997;22(3):219–221. doi: 10.1046/j.1365-2273.1997.00034.x. [DOI] [PubMed] [Google Scholar]
  • 57.Tan R, Corren J. Optimum treatment of rhinitis in the elderly. Drugs Aging. 1995;7:168–175. doi: 10.2165/00002512-199507030-00002. [DOI] [PubMed] [Google Scholar]
  • 58.Kirkegaard J, Mygind N, Molgaard F, et al. Ordinary and high-dose ipratropium in perennial nonallergic rhinitis. J Allergy Clin Immunol. 1987;79:585–590. doi: 10.1016/s0091-6749(87)80153-7. [DOI] [PubMed] [Google Scholar]
  • 59.Greiff L, Andersson M, Akerlund A, et al. Microvascular exudative hyperresponsiveness in human coronavirusinduced common cold. Thorax. 1994;49:121–127. doi: 10.1136/thx.49.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol. 1996;97:1252–1263. doi: 10.1016/S0091-6749(96)70193-8. [DOI] [PubMed] [Google Scholar]

Articles from Current Allergy and Asthma Reports are provided here courtesy of Nature Publishing Group

RESOURCES